COVID‐19 pneumonia and pulmonary microembolism in a patient with B‐thalassemia major

We think that thalassemia is not necessarily a cause of aggravation of the clinical course in COVID‐19; however, certain key factors must be considered, such as the anemic condition, the likely pathogenic role of the virus on hemoglobin, and the hypercoagulable state to prevent any complications. We...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Clinical case reports 2020-12, Vol.8 (12), p.3139-3142
Hauptverfasser:	Marziali, Marco, Ribersani, Michela, Losardo, Anna Annunziata, Taglietti, Fabrizio, Pugliese, Pellegrina, Micozzi, Alessandra, Gentile, Giuseppe, Angeloni, Antonio
Format:	Artikel
Sprache:	eng
Schlagworte:	Anemia Anticoagulants Blood diseases Case Report Case Reports Conflicts of interest Coronaviruses COVID-19 Fever Hemoglobin Hospitalization Illnesses Iron Medical imaging Medical laboratories Oxygen therapy Patients Pneumonia Severe acute respiratory syndrome coronavirus 2 thalassemia
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	We think that thalassemia is not necessarily a cause of aggravation of the clinical course in COVID‐19; however, certain key factors must be considered, such as the anemic condition, the likely pathogenic role of the virus on hemoglobin, and the hypercoagulable state to prevent any complications. We think that thalassemia is not necessarily a cause of aggravation of the clinical course in COVID‐19; however, certain key factors must be considered, such as the anemic condition, the likely pathogenic role of the virus on hemoglobin, and the hypercoagulable state to prevent any complications.
ISSN:	2050-0904 2050-0904
DOI:	10.1002/ccr3.3275